Search Results - "Fromm, F"

Refine Results
  1. 1

    Clinical Aspects of Transporter‐Mediated Drug–Drug Interactions by Gessner, Arne, König, Jörg, Fromm, Martin F.

    Published in Clinical pharmacology and therapeutics (01-06-2019)
    “…Drug transporters play an essential role in disposition and effects of multiple drugs. Plasma concentrations of the victim drug can be modified by drug–drug…”
    Get full text
    Journal Article
  2. 2

    Transporters and drug-drug interactions: important determinants of drug disposition and effects by König, Jörg, Müller, Fabian, Fromm, Martin F

    Published in Pharmacological reviews (01-07-2013)
    “…Uptake and efflux transporters determine plasma and tissue concentrations of a broad variety of drugs. They are localized in organs such as small intestine,…”
    Get full text
    Journal Article
  3. 3

    Importance of P-glycoprotein at blood–tissue barriers by Fromm, Martin F.

    “…P-glycoprotein is the product of the ABCB1 [also known as multidrug resistance 1 ( MDR1)] gene. It translocates a broad variety of xenobiotics out of cells…”
    Get full text
    Journal Article
  4. 4

    Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease by Schumann, Tina, König, Jörg, Henke, Christine, Willmes, Diana M, Bornstein, Stefan R, Jordan, Jens, Fromm, Martin F, Birkenfeld, Andreas L

    Published in Pharmacological reviews (01-01-2020)
    “…The solute carrier (SLC) superfamily comprises more than 400 transport proteins mediating the influx and efflux of substances such as ions, nucleotides, and…”
    Get full text
    Journal Article
  5. 5

    The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine by Taghikhani, Emir, Maas, Renke, Fromm, Martin F, König, Jörg

    Published in PloS one (13-03-2019)
    “…Elevated plasma concentrations of the uremic toxin asymmetrical dimethylarginine (ADMA) and low plasma concentrations of L-homoarginine are independently…”
    Get full text
    Journal Article
  6. 6
  7. 7

    ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin by Keskitalo, JE, Zolk, O, Fromm, MF, Kurkinen, KJ, Neuvonen, PJ, Niemi, M

    Published in Clinical pharmacology and therapeutics (01-08-2009)
    “…The ABCG2 c.421C>A single‐nucleotide polymorphism (SNP) was determined in 660 healthy Finnish volunteers, of whom 32 participated in a pharmacokinetic…”
    Get full text
    Journal Article
  8. 8

    Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein by Knop, Jana, Misaka, Shingen, Singer, Katrin, Hoier, Eva, Müller, Fabian, Glaeser, Hartmut, König, Jörg, Fromm, Martin F

    Published in PloS one (01-10-2015)
    “…Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous…”
    Get full text
    Journal Article
  9. 9

    Transporter-Mediated Drug Uptake and Efflux: Important Determinants of Adverse Drug Reactions by Zolk, O, Fromm, MF

    Published in Clinical pharmacology and therapeutics (01-06-2011)
    “…Transporter proteins mediate the cellular uptake and efflux of a broad variety of endogenous compounds, drugs, and their metabolites. Their systemic plasma…”
    Get full text
    Journal Article
  10. 10

    Transporter-mediated drug-drug interactions by Müller, Fabian, Fromm, Martin F

    Published in Pharmacogenomics (01-07-2011)
    “…Drug-drug interactions are a serious clinical issue. An important mechanism underlying drug-drug interactions is induction or inhibition of drug transporters…”
    Get more information
    Journal Article
  11. 11

    Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates by Hacker, Kristina, Maas, Renke, Kornhuber, Johannes, Fromm, Martin F, Zolk, Oliver

    Published in PloS one (01-09-2015)
    “…The importance of the organic cation transporter OCT2 in the renal excretion of cationic drugs raises the possibility of drug-drug interactions (DDIs) in which…”
    Get full text
    Journal Article
  12. 12

    The quasi-free-standing nature of graphene on H-saturated SiC(0001) by Speck, F., Jobst, J., Fromm, F., Ostler, M., Waldmann, D., Hundhausen, M., Weber, H. B., Seyller, Th

    Published in Applied physics letters (19-09-2011)
    “…We report on an investigation of quasi-free-standing graphene on 6H-SiC(0001) which was prepared by intercalation of hydrogen under the buffer layer. Using…”
    Get full text
    Journal Article
  13. 13

    New Oral Anti-Cancer Drugs and Medication Safety by Schlichtig, Katja, Dürr, Pauline, Dörje, Frank, Fromm, Martin F

    Published in Deutsches Ärzteblatt international (15-11-2019)
    “…Many oral anti-cancer drugs have come onto the market in the past 20 years. For example, kinase inhibitors, such as the BCR-ABL and BRAF inhibitors, have…”
    Get full text
    Journal Article
  14. 14

    Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models by Haberkorn, Bastian, Fromm, Martin F, König, Jörg

    Published in Frontiers in pharmacology (22-04-2021)
    “…Organic Cation Transporter 1 (OCT1, gene symbol: ) is predominately expressed in human liver, localized in the basolateral membrane of hepatocytes and…”
    Get full text
    Journal Article
  15. 15

    A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter‐Mediated Drug‐Drug Interactions by Gessner, Arne, Müller, Fabian, Wenisch, Pia, Heinrich, Markus R., König, Jörg, Stopfer, Peter, Fromm, Martin F.

    Published in Clinical pharmacology and therapeutics (01-11-2023)
    “…Endogenous biomarkers are discussed as tools for detection of drug‐drug interactions (DDIs) mediated by renal transport proteins, such as organic cation…”
    Get full text
    Journal Article
  16. 16

    Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects by Misaka, S, Yatabe, J, Müller, F, Takano, K, Kawabe, K, Glaeser, H, Yatabe, M S, Onoue, S, Werba, J P, Watanabe, H, Yamada, S, Fromm, M F, Kimura, J

    Published in Clinical pharmacology and therapeutics (01-04-2014)
    “…This study aimed to evaluate the effects of green tea on the pharmacokinetics and pharmacodynamics of the β‐blocker nadolol. Ten healthy volunteers received a…”
    Get full text
    Journal Article
  17. 17

    Contribution of the buffer layer to the Raman spectrum of epitaxial graphene on SiC(0001) by Fromm, F, Oliveira Jr, M H, Molina-Sánchez, A, Hundhausen, M, Lopes, J M J, Riechert, H, Wirtz, L, Seyller, T

    Published in New journal of physics (18-04-2013)
    “…We report a Raman study of the so-called buffer layer with periodicity which forms the intrinsic interface structure between epitaxial graphene and SiC(0001)…”
    Get full text
    Journal Article
  18. 18

    Double‐transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations by König, J, Zolk, O, Singer, K, Hoffmann, C, Fromm, MF

    Published in British journal of pharmacology (01-06-2011)
    “…BACKGROUND AND PURPOSE The organic cation transporters 1 (OCT1) and 2 (OCT2) mediate drug uptake into hepatocytes and renal proximal tubular cells,…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Controls and relationships of soil organic carbon abundance and persistence vary across pedo‐climatic regions by Fromm, Sophie F., Hoyt, Alison M., Sierra, Carlos A., Georgiou, Katerina, Doetterl, Sebastian, Trumbore, Susan E.

    Published in Global change biology (01-05-2024)
    “…One of the largest uncertainties in the terrestrial carbon cycle is the timing and magnitude of soil organic carbon (SOC) response to climate and vegetation…”
    Get full text
    Journal Article